- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783540566564
3540566562
9780387566566
0387566562
- Dimensions
-
24 cm
- Extent
-
X, 216 S.
- Language
-
Deutsch
- Notes
-
graph. Darst.
Literaturangaben
- Keyword
-
Verdauungskanal
Krankheit
Arzneimittelschaden
- Event
-
Veröffentlichung
- (where)
-
Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest
- (who)
-
Springer
- (when)
-
1993
- Contributor
-
Guslandi, Mario
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:39 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Aufsatzsammlung
Associated
- Guslandi, Mario
- Springer
Time of origin
- 1993
Other Objects (12)
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Digestive system
New approaches to improve prediction of drug-induced liver injury
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Drug induced liver injury : can biomarkers assist RUCAM in causality assessment?
Epigenetic alterations and analgesic drug activity in injury induced neuropathic pain
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
Identification of drug-specific pathways based on gene expression data: application to drug induced lung injury
Digestive.
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Digestive system
New approaches to improve prediction of drug-induced liver injury
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Drug induced liver injury : can biomarkers assist RUCAM in causality assessment?
Epigenetic alterations and analgesic drug activity in injury induced neuropathic pain
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
Identification of drug-specific pathways based on gene expression data: application to drug induced lung injury
Digestive.
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Digestive system
New approaches to improve prediction of drug-induced liver injury
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Drug induced liver injury : can biomarkers assist RUCAM in causality assessment?
Epigenetic alterations and analgesic drug activity in injury induced neuropathic pain
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
Identification of drug-specific pathways based on gene expression data: application to drug induced lung injury